Lv5
870 积分 2025-04-17 加入
Effects of deuteration on hematopoiesis in the mouse
6天前
已完结
Operationalizing intermediate clinical endpoints: A pragmatic framework for prostate cancer management trials
13天前
已完结
Real-world Comparative Study of Androgen Receptor Signaling Inhibitors in Japanese Patients With Non-metastatic Castration-resistant Prostate Cancer
18天前
已关闭
Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials
19天前
已关闭
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
19天前
已关闭
Phase I clinical trial of HC‐1119: A deuterated form of enzalutamide
23天前
已完结
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
23天前
已关闭
Efficacy and Predictive Factors Analysis of Androgen Deprivation Plus Novel Hormone Therapy as Neoadjuvant Treatment for High‐Risk Prostate Cancer
1个月前
已完结
Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
1个月前
已关闭
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial
1个月前
已完结
皖公网安备34019202002308
